Cheng Tian Selected Research

Cytochalasins

1/2022

Cytochalasin Q exerts anti-melanoma effect by inhibiting creatine kinase B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cheng Tian Research Topics

Disease

13	Neoplasms (Cancer) 11/2022 - 01/2015
4	Inflammation (Inflammations) 01/2022 - 04/2019
3	Neoplasm Metastasis (Metastasis) 11/2022 - 10/2016
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
3	COVID-19 12/2021 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 08/2019 - 10/2016
2	Carcinoma (Carcinomatosis) 01/2020 - 03/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019 - 01/2018
2	Periodontal Diseases (Periodontal Disease) 04/2019 - 12/2017
2	Lymphatic Metastasis 10/2016 - 07/2015
1	Diabetes Mellitus 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Necrosis 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Cytokine Release Syndrome 01/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 04/2020
1	Fatty Liver 01/2020
1	Colonic Neoplasms (Colon Cancer) 08/2019
1	Birth Weight (Birth Weights) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Seizures (Absence Seizure) 01/2018
1	Epilepsy (Aura) 01/2018
1	Rhinosinusitis 01/2018
1	Rheumatoid Arthritis 12/2017
1	Papillary Thyroid Cancer 07/2015
1	Dental Pulp Exposure 12/2013
1	Alzheimer Disease (Alzheimer's Disease) 11/2013
1	Postoperative Cognitive Complications 11/2013
1	Hypothermia 11/2013
1	Cognitive Dysfunction 11/2013
1	Fibrosis (Cirrhosis) 04/2012
1	Carcinoma in Situ 03/2012
1	Squamous Cell Carcinoma of Head and Neck 03/2012
1	Rhinoscleroma 06/2009

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2022 - 12/2017
3	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2021 - 10/2016
3	CollagenIBA 04/2019 - 04/2012
2	RNA (Ribonucleic Acid)IBA 11/2022 - 12/2021
2	EnzymesIBA 01/2022 - 01/2019
2	Opioid Receptors (Opioid Receptor)IBA 09/2020 - 01/2020
2	Glycoproteins (Glycoprotein)IBA 08/2019 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 09/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2022
1	3-glucopyranosyloxybutanolideIBA 01/2022
1	Interleukin-33IBA 01/2022
1	Pancreatitis-Associated ProteinsIBA 01/2022
1	Phosphocreatine (Neoton)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	CreatineIBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	CytochalasinsIBA 01/2022
1	Viral RNAIBA 12/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	VaccinesIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Methionine EnkephalinIBA 09/2020
1	Mitogen-Activated Protein KinasesIBA 04/2020
1	Pattern Recognition ReceptorsIBA 04/2020
1	GlycolipidsIBA 01/2020
1	LipidsIBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	argatroban (MPQA)FDA Link 01/2020
1	ginsenoside Rh2IBA 11/2019
1	DioxygenasesIBA 04/2019
1	LipopolysaccharidesIBA 04/2019
1	Ribosomal DNA (rDNA)IBA 01/2019
1	Volatile Fatty AcidsIBA 01/2019
1	OccludinIBA 01/2019
1	Sincalide FDA Link 01/2019
1	SitosterolsIBA 01/2019
1	gamma-sitosterol (beta-sitosterol)IBA 01/2019
1	Annexin A5IBA 01/2019
1	SugarsIBA 01/2019
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2019
1	ClaudinsIBA 01/2019
1	BerberineIBA 01/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018
1	AntibodiesIBA 01/2018
1	8-cetylberberineIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Angiogenesis InhibitorsIBA 01/2018
1	coptisineIBA 01/2017
1	TubulinIBA 10/2016
1	Aldehyde DehydrogenaseIBA 07/2015
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 04/2012
1	Formaldehyde (Formol)FDA Link 03/2012
1	ParaffinIBA 03/2012
1	telomerase RNA (bTR)IBA 03/2012

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2018
2	Oral Administration 01/2019 - 01/2018
1	Transplantation 01/2022
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Length of Stay 01/2020
1	Nephrectomy 01/2015
1	Anesthesia 11/2013